BioNTech Reaches $1.26 Billion Settlement Over COVID-19 Vaccine Royalties
Washington, U.S. – BioNTech (22UAy.DE), the German biotech firm that developed a COVID-19 vaccine in partnership with Pfizer (PFE.N), has resolved royalty disputes with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania (Penn). The company announced two separate settlement agreements totalling $1.26 billion to address allegations of underpaid royalties related to…